Serum biomarkers such as high-sensitivity copeptin (CPus), high-sensitivity procalcitonin (PCTus), and mid-regional pro-adrenomedullin (MRproADM) were strongly associated with SAP and unfavorable post-stroke outcomes, with CPus and PCTus identified as independent predictors of SAP. Here, ADM is linked to stroke disorder.